Table 1.
Patient characteristics and tumor entities
| |
Age [years] |
|||
|---|---|---|---|---|
| n | % | Median | Range | |
|
All patients |
151 |
100 |
64.8 |
18.5- 84.4 |
| Male |
84 |
55.6 |
|
|
| Female |
67 |
44.4 |
|
|
|
Malignancy |
|
|
|
|
|
Group I: lung cancer |
37 |
24.5 |
62.8 |
43.9- 83.5 |
| Adeno |
15 |
9.9 |
|
|
| Small cell |
10 |
6.6 |
|
|
| Squamous |
10 |
6.6 |
|
|
| Other non small cell |
2 |
1.3 |
|
|
|
Group II: breast cancer |
10 |
6.6 |
55.9 |
34.9- 71.3 |
| Ductal |
9 |
90 |
|
|
| Lobular |
1 |
10 |
|
|
|
Group III: gastrointestinal |
16 |
10.6 |
67.5 |
42.3- 84.4 |
| Stomach cancer |
3 |
2.0 |
|
|
| Colorectal cancer |
7 |
4.6 |
|
|
| Other |
6 |
4.0 |
|
|
|
Group IV: hematological |
62 |
41.1 |
64.2 |
18.5- 83.2 |
| Acute myeloid leukemia |
7 |
4.6 |
|
|
| Chronic myelogenous leukemia |
2 |
1.3 |
|
|
| Hodgkin’s lymphoma |
5 |
3.3 |
|
|
| Non-Hodgkin’s lymphoma |
13 |
8.6 |
|
|
| Other lymphoma |
7 |
4.6 |
|
|
| Multiple myeloma |
13 |
8.6 |
|
|
| Idiopathic thrombocytopenia |
5 |
3.3 |
|
|
| Myelodysplastic syndrome |
10 |
6.6 |
|
|
|
Group V: urogenital cancers |
8 |
5.3 |
64.4 |
38.4- 81.7 |
| Ovarian cancer |
2 |
1.3 |
|
|
| Testicular cancer |
2 |
1.3 |
|
|
| Prostate cancer |
1 |
0.7 |
|
|
| Urinary tract cancer |
3 |
2.0 |
|
|
|
Group VI: CUP |
5 |
3.3 |
64.7 |
41.2- 80.6 |
| Group VII: other solid tumors | 13 | 8.6 | 64.1 | 30.7- 73.5 |